Pedro A. Moreno-Sanchez

Dr. Pedro A. Moreno-Sanchez

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2023 in IEEE Access
Verified
Journal Article
Open access
PMPedro A. Moreno-Sanchez
Pedro A. Moreno-Sanchez
Chronic Kidney Disease (CKD) is currently experiencing a growing worldwide incidence and can lead to premature mortality if diagnosed late, resulting in rising costs to healthcare systems. Artificial Intelligence (AI) and Machine Learning (ML) offer the possibility of an early diagnosis of CKD that could revert further kidney damage. However, clinicians may be hesitant to adopt AI models if the reasoning behind the predictions is not understandable. Since eXplainable AI (XAI) addresses the clinicians’ requirement of understanding AI models’ output, this work presents the development and evaluation of an explainable CKD prediction model that provides information about how different patient’s clinical features contribute to CKD early diagnosis. The model was developed using an optimization framework that balances classification accuracy and explainability. The main contribution of the paper lies in an explainable data-driven approach to offer quantitative information about the contribution of certain clinical features in the early diagnosis of CKD. As a result, the optimal explainable prediction model implements an extreme gradient boosting classifier using 3 features (hemoglobin, specific gravity, and hypertension) with an accuracy of 99.2% (standard deviation 0.8) and 97.5% with a 5-fold cross-validation and with new unseen data respectively. In addition, an explainability analysis shows that hemoglobin is the most relevant feature that influences the prediction, followed by specific gravity and hypertension. This small number of features selected results in a reduced cost of the early diagnosis of CKD implying a promising solution for developing countries.

28 February 2024 in Computers in Biology and Medicine
Verified
Journal Article
Open access
PMPedro A. Moreno-Sanchez
Pedro A. Moreno-Sanchez
GGGuadalupe García-Isla
Guadalupe García-Isla
VCValentina Corino
Valentina Corino
AVAntti Vehkaoja
Antti Vehkaoja
KBKirsten Brukamp
Kirsten Brukamp
LMLuca Mainardi
Luca Mainardi
Cardiovascular diseases (CVD) are a leading cause of death globally, and result in significant morbidity and reduced quality of life. The electrocardiogram (ECG) plays a crucial role in CVD diagnosis, prognosis, and prevention; however, different challenges still remain, such as an increasing unmet demand for skilled cardiologists capable of accurately interpreting ECG. This leads to higher workload and potential diagnostic inaccuracies. Data-driven approaches, such as machine learning (ML) and deep learning (DL) have emerged to improve existing computer-assisted solutions and enhance physicians' ECG interpretation of the complex mechanisms underlying CVD. However, many ML and DL models used to detect ECG-based CVD suffer from a lack of explainability, bias, as well as ethical, legal, and societal implications (ELSI). Despite the critical importance of these Trustworthy Artificial Intelligence (AI) aspects, there is a lack of comprehensive literature reviews that examine the current trends in ECG-based solutions for CVD diagnosis or prognosis that use ML and DL models and address the Trustworthy AI requirements. This review aims to bridge this knowledge gap by providing a systematic review to undertake a holistic analysis across multiple dimensions of these data-driven models such as type of CVD addressed, dataset characteristics, data input modalities, ML and DL algorithms (with a focus on DL), and aspects of Trustworthy AI like explainability, bias and ethical considerations. Additionally, within the analyzed dimensions, various challenges are identified. To these, we provide concrete recommendations, equipping other researchers with valuable insights to understand the current state of the field comprehensively.

1 August 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PMPedro A. Moreno-Sanchez
Pedro A. Moreno-Sanchez
Cardiovascular diseases and their associated disorder of heart failure (HF) are major causes of death globally, making it a priority for doctors to detect and predict their onset and medical consequences. Artificial Intelligence (AI) allows doctors to discover clinical indicators and enhance their diagnoses and treatments. Specifically, “eXplainable AI” (XAI) offers tools to improve the clinical prediction models that experience poor interpretability of their results. This work presents an explainability analysis and evaluation of two HF survival prediction models using a dataset that includes 299 patients who have experienced HF. The first model utilizes survival analysis, considering death events and time as target features, while the second model approaches the problem as a classification task to predict death. The model employs an optimization data workflow pipeline capable of selecting the best machine learning algorithm as well as the optimal collection of features. Moreover, different post hoc techniques have been used for the explainability analysis of the model. The main contribution of this paper is an explainability-driven approach to select the best HF survival prediction model balancing prediction performance and explainability. Therefore, the most balanced explainable prediction models are Survival Gradient Boosting model for the survival analysis and Random Forest for the classification approach with a c-index of 0.714 and balanced accuracy of 0.74 (std 0.03) respectively. The selection of features by the SCI-XAI in the two models is similar where “serum_creatinine”, “ejection_fraction”, and “sex” are selected in both approaches, with the addition of “diabetes” for the survival analysis model. Moreover, the application of post hoc XAI techniques also confirm common findings from both approaches by placing the “serum_creatinine” as the most relevant feature for the predicted outcome, followed by “ejection_fraction”. The explainable prediction models for HF survival presented in this paper would improve the further adoption of clinical prediction models by providing doctors with insights to better understand the reasoning behind usually “black-box” AI clinical solutions and make more reasonable and data-driven decisions.

Wasim AhmedWasim Ahmed
Wasim Ahmed
Josep Vidal-AlaballJosep Vidal-Alaball
Josep Vidal-Alaball
FSFrancesc López Seguí
Francesc López Seguí
PMPedro A. Moreno-Sanchez
Pedro A. Moreno-Sanchez
Background: High compliance in wearing a mask is a crucial factor for stopping the transmission of COVID-19. Since the beginning of the pandemic, social media has been a key communication channel for citizens. This study focused on analyzing content from Twitter related to masks during the COVID-19 pandemic. Methods: Twitter data were collected using the keyword “mask” from 27 June 2020 to 4 July 2020. The total number of tweets gathered were n = 452,430. A systematic random sample of 1% (n = 4525) of tweets was analyzed using social network analysis. NodeXL (Social Media Research Foundation, California, CA, USA) was used to identify users ranked influential by betweenness centrality and was used to identify key hashtags and content. Results: The overall shape of the network resembled a community network because there was a range of users conversing amongst each other in different clusters. It was found that a range of accounts were influential and/or mentioned within the network. These ranged from ordinary citizens, politicians, and popular culture figures. The most common theme and popular hashtags to emerge from the data encouraged the public to wear masks. Conclusion: Towards the end of June 2020, Twitter was utilized by the public to encourage others to wear masks and discussions around masks included a wide range of users.


29 July 2022 in IEEE Transactions on Technology and Society
Verified
Journal Article
Open access
HAHimanshi Allahabadi
Himanshi Allahabadi
JAJulia Amann
Julia Amann
IBIsabelle Balot
Isabelle Balot
ABAndrea Beretta
Andrea Beretta
CBCharles Binkley
Charles Binkley
RZRoberto V. Zicari
Roberto V. Zicari
The paper’s main contributions are twofold: to demonstrate how to apply the general European Union’s High-Level Expert Group’s (EU HLEG) guidelines for trustworthy AI in practice for the domain of healthcare; and to investigate the research question of what does “trustworthy AI” mean at the time of the COVID-19 pandemic. To this end, we present the results of a post-hoc self-assessment to evaluate the trustworthiness of an AI system for predicting a multi-regional score conveying the degree of lung compromise in COVID-19 patients, developed and verified by an interdisciplinary team with members from academia, public hospitals, and industry in time of pandemic. The AI system aims to help radiologists to estimate and communicate the severity of damage in a patient’s lung from Chest X-rays. It has been experimentally deployed in the radiology department of the ASST Spedali Civili clinic in Brescia (Italy) since December 2020 during pandemic time. The methodology we have applied for our post-hoc assessment, called Z-Inspection, uses socio-technical scenarios to identify ethical, technical and domain-specific issues in the use of the AI system in the context of the pandemic.